Holding(s) in Company
Nicholas Christian Paul Nelson's notification to Solvonis Therapeutics Plc indicates a change in the breakdown of voting rights, with his holding now representing 2.6% of the voting rights, totaling 205,961,538 shares. This change occurred on September 30, 2026, following an issue of new shares by the issuer, some of which were allocated to Mr. Nelson. The notification was made on October 15, 2026, and it is confirmed that Mr. Nelson is not controlled by any other entity and does not control any other undertakings holding an interest in the issuer.
Select text to share a quote on X · sign in to keep highlights & notes in your SVNS notes
Non-UK issuer
- Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments
| An event changing the breakdown of voting rights | x |
Other (please specify) iii :
Details of person subject to the notification obligation iv
| Name | Nicholas Christian Paul Nelson |
City and country of registered office (if applicable)
Full name of shareholder(s) (if different from 3.) v
Name
City and country of registered office (if applicable)
| 5. Date on which the threshold was crossed or reached vi : | 30/09/2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 15/10/2026 |
- Total positions of person(s) subject to the notification obligation
| % of voting rights attached to shares (total of 8. A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer (8.A + 8.B) vii | |
|---|---|---|---|---|
| Resulting situation on the date on which threshold was crossed or reached | 205,961,538 | 2.6 | ||
| Position of previous notification (if applicable) | 205,961,538 | |||
| A: Voting rights attached to shares | ||||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | ||
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) | |
| GB00BMD1Z199 | 205,961,538 | 2.6 | ||
| SUBTOTAL 8. A | 205,961,538 | 2.6 | ||
| B 1: Financial Instruments according to DTR5.3.1R (1) (a) | ||||
| Type of financial instrument | Expiration date x | Exercise/ Conversion Period xi | Number of voting rights that may be acquired if the instrument is exercised/converted. | % of voting rights |
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
| Type of financial instrument | Expiration date x | Exercise/ Conversion Period xi | Physical or cash Settlement xii | Number of voting rights | % of voting rights |
| N/A | |||||
| SUBTOTAL 8.B.2 | |||||
| Name xv | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold | ||
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
Changed percentage is following an issue of new shares by the issuer plus the issue of some of those new shares to the person (above) subject to the notification
| Place of completion | London, UK |
| Date of completion | 15/10/2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.